Author

Dijie Liu

Institutions: University of Iowa, University of Iowa Holden Comprehensive Cancer Center

Observed institutions: University of Iowa, Viewpoint Molecular Targeting (United States), University of Iowa Holden Comprehensive Cancer Center

ORCID: 0000-0003-4544-8397

Observed ORCID: 0000-0003-4544-8397

OpenAlex ID: A5048812704

Dosimetry of [212Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free 208Tl on Tissue Absorbed Doses

2022 · Kelly D. Orcutt, Kelly E. Henry, et al. · Molecules · 17

Targeting CXCR4 with 212Pb/203Pb-Pentixather Significantly Increases Overall Survival in Small Cell Lung Cancer

2025 · Keegan A. Christensen, Melissa A. Fath, et al. · Radiation Research · 5

[212Pb]PSC-PEG2-TOC Therapy for NET Leads to Complete Responses in Mice Bearing SSTR2 Positive Tumors - Comparison to [177Lu]DOTATATE in a Preclinical Model

2023 · Michael K. Schultz, Dijie Liu, et al. · Endocrine Abstracts

Works count: 3

Citation count: 22

H-index: 2

I10-index: 1